Marinus Pharmaceuticals (MRNS) Amount of Cash per Share

Corporate emblem and logo of Marinus Pharma (MRNS)

Marinus Pharmaceuticals (MRNS) is integrating ESG principles into the development of neurological drugs while strictly adhering to bioethics. The cash per share trend on the precise GURU.Markets chart illustrates liquidity, where 0.79 represents the current metric level. The stable US legal framework and the humanitarian status of the developments minimize geopolitical risks. High physician confidence in the brand confirms success in the therapy of rare seizure disorders.

Cash per Share: Marinus Pharmaceuticals, Inc. (MRNS) for 07/04/2022 - 02/22/2025

Comprehensive metric breakdowns and analytics for Marinus Pharma (MRNS)

- price and consensus price forecast:
- market capitalization details:
- cash position and cash flow details:
General company analysis:MRNS, Marinus Pharmaceuticals
Signature product of Marinus

For Marinus Pharmaceuticals (MRNS), which is expanding the application of ZTALMY in neurology, the cash per share figure reflects the current liquidity reserve available to fund expansion. This metric determines the portion of free cash resources attributable to a single security. The calculation is based on the ratio of total cash holdings to the number of shares outstanding. The indicator's trend captures the balance between capital preservation and investments in clinical programs. It is critical for investors to assess this reserve as a guarantee of the company's operational stability.

Competing companies

Biogen Corp (BIIB) - Cash Funds Calculated per Share|Cash per Share NBIX|RGC - Cash on Hand per Share|Cash Funds per Share Axsome Therapeutics AXSM|Cash per Share ACADIA Pharmaceuticals Inc. ACAD|xenon-pharma.com - Cash per Share|Cash on Hand per Share Viking Therapeutics|SUPN: Cash per Share|Catalyst Pharmaceuticals (CPRX) - Cash per Share|Cash per Single Share DNLI|Cash Funds per Single Share HRMY (Harmony Biosciences Holdings, Inc.)|Cash Funds per Share Biohaven Ltd. (BHVN)|Cash Calculated per Single Share AMLX|Cash Funds per Share trevitherapeutics.com TRVI|PRAX - Cash per Single Share|Anavex Life Sciences Corp - Cash per Share|Cash on Hand per Share CeriBell Corp|Prothena Corporation PLC (PRTA) - Cash Funds per Share|Alector Therapeutics - Amount of Cash per Share|Cash Funds per Share Annexon Biosciences|Cash on Hand per Share omeros.com OMER|Cash Funds per Share Neurogene (NGNE)|Cash Funds Calculated per Share AC Immune S.A.|Cash per Share VYGR (Voyager Therapeutics Inc)|Amount of Cash per Share NMRA|scilexholding.com - Cash per Share|TVGN (tevogen.com) - Cash Funds per Single Share|ACOG: Cash per Share|CGTX: Cash Calculated per Single Share|Cash Funds per Share Inhibikase Therapeutics|Cash Funds per Single Share SAVA (Cassava)|Cash Funds per Share Assertio Therapeutics (ASRT)|Coya Therapeutics - Cash Funds per Single Share|VistaGen Therapeutics, Inc. - Cash per Single Share|ovidrx.com (OVID) - Cash on Hand per Share|ABOS: Cash per Single Share|Cash on Hand per Share CervoMed Inc|alteritytherapeutics.com (ATHE) - Cash Funds per Share|Cash per Single Share Clene Nanomedicine|Cash per Single Share PEPG|Cash on Hand per Share Jupiter Neurosciences JUNS|Cash Funds per Share Relmada (RLMD)|Cash Funds Calculated per Share Annovis Bio, Inc.|Cash per Share GRCE (Grace Tx)|Firefly Neuroscience, Inc (AIFF) - Cash on Hand per Share|KLTO - Cash Funds per Share|Cash on Hand per Share NeuroSense Therapeutics Ltd|RVPH: Cash per Share|MetaVia, Inc. (MTVA) - Cash per Share|Cash Funds per Share NeurAxis|Cash per Share heliusmedical.com|Cash per Single Share PASG (Passage Bio Inc.)|Neuphoria Therapeutics - Cash Funds per Single Share|Minerva Neurosciences Corp - Cash per Single Share|Amount of Cash per Share ATHA|ADXN - Cash Funds per Share|Cash on Hand per Share Alzamend Neuro Inc.|Cyclerion Therapeutics (CYCN) - Cash Funds per Share|Cash Funds per Single Share PTIX|KTTA (pasitheaclinics.com) - Cash per Share|CRGT (cortigent.com) - Cash Calculated per Single Share|Cash per Share ATXI|Cash Funds per Share BCLI (Brainstorm Cell)|Cash per Share CARA (Cara Therapeutics Inc)|Amount of Cash per Share CHRO|Eliem Therapeutics Inc. - Cash per Share|ITCI - Cash per Share|Longboard Pharma (LBPH) - Cash Funds per Share|NKGN - Cash Funds Calculated per Share|NRBO (neurobopharma.com) - Cash per Share|Sage Therapeutics (SAGE) - Cash Funds Calculated per Share|Cash per Single Share SNPX (Synaptogenix, Inc.)|TRVN - Cash on Hand per Share|Cash per Share VIGL (Vigil Neuro)|WENA: Cash Funds per Single Share|CERE - Cash Funds per Share